Anti-VEGF Monotherapy Versus Photodynamic Therapy and Anti-VEGF Combination Treatment for Neovascular Age-Related Macular Degeneration: A Meta-Analysis | Zendy

Yang Gao | Zendy; Tao Yu | Zendy; Yue Zhang | Zendy; Guangfu Dang | Zendy

Open Access

Anti-VEGF Monotherapy Versus Photodynamic Therapy and Anti-VEGF Combination Treatment for Neovascular Age-Related Macular Degeneration: A Meta-Analysis

Author(s) -

Yang Gao,

Tao Yu,

Yue Zhang,

Guangfu Dang

Publication year - 2018

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.17-23747

Subject(s) - verteporfin , medicine , combination therapy , photodynamic therapy , macular degeneration , confidence interval , ophthalmology , randomized controlled trial , meta analysis , oncology , urology , surgery , choroidal neovascularization , chemistry , organic chemistry

The purpose of this study was to compare the efficacy and safety of anti-VEGF monotherapy with verteporfin photodynamic therapy (PDT) and anti-VEGF combination treatment in neovascular AMD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research